Previous studies demonstrated the effectiveness of selective r-receptor (rR) agonists [1,, as reinforcers in rats trained to selfadminister cocaine. Similar to cocaine, these drugs increased nucleus accumbens shell dopamine levels, and effects of DTG, but not PRE-084, on dopamine seemed to be mediated by rRs. In addition, rR antagonists blocked self-administration of rR agonists, but were inactive against reinforcing and neurochemical effects of cocaine. Thus, pharmacologically distinct mechanisms likely underlie the reinforcing and neurochemical effects of rR agonists and cocaine. This study further examined the cocaine-like effects of rR agonists in rats trained to discriminate injections of cocaine from saline to assess the similarity of their subjective effects. Standard dopamineuptake inhibitors (WIN 35 428, methylphenidate), but neither rR agonist (PRE-084, DTG), produced full cocainelike discriminative-stimulus effects. The lack of effects of rR agonists was obtained regardless of route of administration (intraperitoneal, subcutaneous, or intravenous) or pretreatment time (5 or 30 min before sessions). The present results demonstrate differences in the discriminative-stimulus effects of cocaine and selective rR agonists, indicating that an overlap of subjective effects is not necessary for rR agonist self-administration. The previously found differences in neurochemical effects of cocaine and rR agonists may contribute to their different subjective effects. Behavioural Pharmacology 22:525-530
Introduction
Previous studies have suggested a role for the s receptor (sR) in several of the behavioral effects of cocaine. For example, an early study showed that the sR antagonists, BMY 14 802 and rimcazole, blocked the locomotor stimulant effects of cocaine at doses that were inactive when administered alone (Menkel et al., 1991) . This antagonist action was more selective than that obtained with dopamine receptor antagonists, which only blocked the locomotor-stimulant effects of cocaine at doses that also decreased activity when administered alone (see also Chausmer and Katz, 2001) . Other studies showed that more selective sR antagonists, such as 1- [2-(3,4dichlorophenyl) -ethyl]-4-methylpiperazine (BD 1063), blocked cocaine-induced locomotor stimulant effects, as well as the convulsions and lethality in mice (Matsumoto et al., 2001) . In further studies, several sR antagonists attenuated the development of cocaine-induced locomotor sensitization (Ujike et al., 1992; Witkin et al., 1993) . These studies prompted other studies described below on the role of sRs in various behavioral effects related to the abuse liability of stimulant drugs.
Several studies have indicated that, despite the abovecited antagonism of cocaine by several sR antagonists, sR agonists were devoid of cocaine-like behavioral effects. For example, the sR agonist (+)-pentazocine did not affect locomotor activity in naive mice (Okuyama et al., 1996) . Other sR agonists, 1,3-di-o-tolylguanidine (DTG) and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (SA 4503), only decreased locomotor activity in rats across the range of behaviorally active doses (Maj et al., 1996; Rodvelt et al., 2011a Rodvelt et al., , 2011b . In contrast, the sR agonist DTG potentiated cocaine-induced locomotor stimulant effects in rats (Skuza, 1999) . In rats trained to discriminate injections of 10-mg/kg cocaine from saline in a shock avoidance procedure, DTG (1 and 10 mg/kg, 30 min before sessions) failed to produce effects different from vehicle (Ukai et al., 1997) . Furthermore, a recent study on substitution of the sR agonist, SA 4503, for cocaine (5 mg/kg) demonstrated that SA 4503 produced at most partial, but not full, substitution in rats trained with food to discriminate injections of cocaine from saline under a fixed-ratio 10-response schedule of reinforcement (Rodvelt et al., 2011a) .
Consistent with the lack of stimulant-like effects of sR agonists, (+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethylbut-3-en-1-ylamine hydrochloride (igmesine) and 2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate hydrochloride (PRE-084), both selective sR agonists, failed to produce place conditioning under conditions in which cocaine was effective (Romieu et al., 2002) . In contrast, sR antagonists given in combination with cocaine can block the development of a place preference (Romieu et al., 2000) . The place conditioning studies together with those focused on locomotor activity with sR agonists and antagonists suggest that stimulation of sRs is necessary but insufficient for these two effects of cocaine.
In other studies, the sR agonist, igmesine, reinstated a previously extinguished cocaine place-conditioned response in mice (Romieu et al., 2004) . In addition, a recent study from our laboratory indicated that the sR agonists, DTG and PRE-084, were reinforcing in rats with a history of cocaine self-administration (Hiranita et al., 2010) . Furthermore, both sR agonists increased dopamine concentrations in the shell of the nucleus accumbens and those effects of DTG, but not PRE-084 were antagonized by the sR antagonist, BD 1008 (Garcés-Ramírez et al., 2011) . In contrast, sR antagonists neither had any effect on cocaine self-administration (Hiranita et al., 2010 ; see also Martin-Fardon et al., 2007) nor on cocaine-induced increases in nucleus accumbens dopamine (Garcés-Ramírez et al., 2011) . In addition, pretreatment with intraperitoneal (i.p.) injections of PRE-084 or DTG before sessions produced leftward shifts in the cocaine self-administration dose-effect curve, suggesting an additive effect or possibly a potentiation of the reinforcing effects of cocaine (Hiranita et al., 2010) .
These studies were prompted by the findings by Romieu et al. (2004) and Hiranita et al. (2010) , and re-examined the potential of sR agonists to produce cocaine-like discriminative-stimulus effects. A substantial overlap with cocaine in the discriminative (subjective) effects of these drugs would hypothetically explain the sR agonist-induced reinstatement of place conditioning or the substitution of sR agonists in subjects trained to selfadminister cocaine. Thus, this study examined the substitution of the sR agonists, PRE-084 or DTG, for cocaine in rats trained with food to discriminate injections of cocaine from saline under a fixed-ratio 20response schedule of reinforcement. We compared cocaine-like discriminative-stimulus effects of the sR agonists with those of standard dopamine-uptake inhibitors, WIN 35 428 and methylphenidate. In a previous study, both sR agonists potentiated the reinforcing effects of cocaine, when pretreated i.p. 30 min before sessions (Hiranita et al., 2010) . In addition, intravenous (i.v.) injections of DTG maintained responding, when substituted for those of cocaine. In contrast, subcutaneous (s.c.) injections of DTG 30 min before sessions have been reported to produce their own discriminative-stimulus effects in naive rats (Holtzman, 1989) . Therefore, both agonists were injected either i.p., s.c., or i.v.
Methods

Subjects
Male Sprague-Dawley rats (weighing approximately 300 g at the start of the study), obtained from Taconic Farms (Germantown, New York, USA), served as subjects after acclimation to the laboratory for at least 1 week. Food (Scored Bacon Lover Treats, Bioserv, Frenchtown, New Jersey, USA) and tap water were available in their home cages. After acclimation, weights of rats were maintained at approximately 320 g by adjusting their daily food ration. The animal housing room was temperature-controlled and humidity-controlled and maintained on a 12 : 12-h light:dark cycle with lights on at 07 : 00 h. Care of the subjects was in accordance with the guidelines of the National Institutes of Health and the National Institute on Drug Abuse Intramural Research Program Animal Care and Use Program that is fully accredited by AAALAC International.
Apparatus
Experimental sessions were conducted with rats placed in operant-conditioning chambers (modified ENV-203; Med Associates Inc., St Albans, Vermont, USA) having inside measurements of 23.0 cm L Â 29.0 cm W Â 21.0 cm H. These chambers were enclosed within sound-attenuating cubicles equipped with a fan for ventilation and white noise to mask extraneous sounds. On the front wall of each chamber there were two response levers, 5.0 cm from the midline and 4.0 cm above the grid floor. A downward displacement of a lever with a force approximately 20 g defined a response that always activated a relay mounted behind the front wall of the chamber producing an audible 'feedback' click. Three lightemitting diodes were located in a row above each lever. A receptacle for the delivery of food pellets was mounted behind a 5.0 Â 5.0-cm opening in the front wall midline between the two levers and 2.0 cm above the floor.
Procedures
Rats were initially trained with food reinforcement to press both levers, and were eventually trained to press one after cocaine (10 mg/kg, i.p.), and the other after saline (i.p.) injection. The ratio of responses to food pellets [fixed ratio (FR)] was gradually increased until, under the final conditions, the completion of 20 consecutive responses on the cocaine-appropriate or salineappropriate lever, produced a food pellet delivery. Incorrect responses reset the FR response requirement. The right-assignment versus left-assignment of cocaineassociated and saline-associated levers was counterbalanced among subjects.
Subjects were placed in chambers immediately after injection. There was a 5-min timeout period during which lights were off and responses produced an audible click, but had no other scheduled consequences. After the timeout period, the house light was turned on until the completion of the FR 20 response requirement. Food presentation was followed by a 20-s timeout during which all lights were off and responses had no scheduled consequences other than the feedback click. Sessions ended after 20 food presentations or 15 min, whichever occurred first. Cocaine or saline training sessions were scheduled in a double-alternation sequence (i.e. cocainesaline-saline-cocaine). Training continued until subjects met the criteria in four consecutive sessions of at least 85% cocaine-appropriate or saline-appropriate responding over the entire session, and during the first FR of the session.
Once these criteria were met, testing began. Test sessions were conducted with the administration of different doses of cocaine, standard dopamine-uptake inhibitors (WIN 35 428 and methylphenidate) or selective sR agonists (PRE-084 and DTG) before sessions. Test sessions were identical to training sessions with the exception that the completion of the FR requirement on either lever was reinforced. All data collection and programming of behavioral contingencies were accomplished with software from Med Associates Inc.
For habituation to i.v. injections, subjects were placed daily before sessions for several minutes into a flat bottom restrainer (model FB-LG, Braintree Scientific Inc., Braintree, MA, USA), which measured 8.57 cm diameter Â 21.59 cm. Subjects were intravenously injected with saline (1.0 ml/kg) inside the restrainer, removed from the restraint, and then given an i.p. injection of saline or cocaine (10 mg/kg) until the above training criteria were met. As described above, subjects were tested with i.v. injection of different doses of cocaine DTG, or PRE-084 in a volume of 1.0 mg/ml administered in the restrainer, followed by an i.p. injection of saline (1.0 ml/kg) 5 min before sessions.
Drugs
The following drugs were used: ( -)-cocaine hydrochloride (Sigma-Aldrich, St Louis, Missouri, USA; molecular weight: 339.8), WIN 35 428 [( -)-3b-(4-fluorophenyl)tropan-2b-carboxylic acid methyl ester tartrate, NIDA, Drug Supply Program; molecular weight: 443.9], methylphenidate hydrochloride (NIDA; molecular weight: 269.8), PRE-084 hydrochloride (Tocris, Ballwin, Missouri, USA; molecular weight: 353.9), and DTG (Sigma-Aldrich; molecular weight: 239.3). Drug pretreatments were administered by the i.p., s.c., or i.v. routes. Cocaine, WIN 35 428, and methylphenidate were administered i.p. 5 min before sessions. In addition, PRE-084 and DTG were administered i.p. or i.v. at 5 or 30 min before sessions or s.c. at 30 min before sessions. All drug solutions were prepared fresh daily in 0.9% NaCl, with the exception of DTG (initially dissolved in 1 N HCl and neutralized with 1 N NaOH). Pretreatment times and doses of drugs used in this study were chosen based on published data (Hiranita et al., 2010; Garcés-Ramírez et al., 2011) or preliminary data obtained in this laboratory.
Data analysis
The percentage of cocaine lever responding was calculated by dividing the total number of responses on the cocaine-associated lever by the total number of responses. Rate of responding was calculated by dividing the total number of responses by the session time (excluding timeout periods) and is expressed as percentage of saline (control) rate of responding. These data are shown as mean values (± SEM) for groups of subjects at each drug dose. Response rate exclusion criteria were applied to the percent cocaine lever selection data such that any dose at which more than half of the sample size did not respond was considered a potentially unreliable indication of lever selection and was removed from the analysis. Dose-effect curves for percent cocaine lever responding were analyzed using standard linear regression techniques, from which ED 50 values with 95% confidence limits (Snedecor and Cochran, 1967) were calculated. Only points on the linear part of the ascending portions of the dose-effect curves were used. For compounds that did not fully substitute for cocaine standard analysis of variance was conducted to determine whether drug substitution differed from saline vehicle controls. Comparisons were considered significant when P value was less than 0.05.
Results
Cocaine produced a dose-dependent increase in the percentage of responses on the cocaine-appropriate lever ( Fig. 1a and b , top panels, filled circles), with an ED 50 value of 9.62 mmol/kg (Table 1) . Similar dose-dependent effects of the dopamine-uptake inhibitors, WIN 35 428 and methylphenidate, were obtained (Fig. 1a, top panel, open circles and circles with cross hatch, respectively). WIN 35 428 was approximately 10-fold and methylphenidate three-fold more potent than cocaine on a molar basis (Table 1) . Cocaine did not affect response rates across the range of doses tested, whereas both WIN 35 428 and methylphenidate decreased rates of responding at the highest doses tested (Fig. 1a, bottom panel) .
In contrast to the dopamine-uptake inhibitors, neither of the sR agonists, PRE-084 nor DTG, substituted for cocaine when administered i.p. at either 5 or 30 min before testing (Fig. 1b, top panel, open symbols) . The percent cocaine-appropriate responding was not statistically different from that obtained with vehicle [(all F values < 1.43; not significant (NS)]. Both PRE-084 and DTG were studied at doses from those that had no effects on the rates of responding to those that decreased response rates to less than 50% of control response rates (Fig. 1b, bottom panel, open symbols) . When tested 30 min after s.c. administration (Fig. 1c) , the overall analysis of variance for DTG was significant (F 4,20 = 3.78; P < 0.02), though post-hoc comparisons indicated that effects at no dose were significantly different from vehicle. The effects of PRE-084 tested 30 min after s.c.
Lack of cocaine-like effects of r agonists Hiranita et al. 527 administration were not significant (F 5,20 = 1.05; NS). The highest dose of DTG decreased response rates to less than 50% of control, whereas PRE-084 administered s.c. had no effects on response rates up to 32 mg/kg (Fig. 1c, lower panel) .
Intravenous injections of cocaine produced a dosedependent increase in the percentage of responses on the cocaine-appropriate lever (Fig. 1d, top panels, open circles), with an ED 50 value of 0.241 mmol/kg (Table 1) . The potency of i.v. cocaine was approximately 40-fold greater than that for the i.p. route. Across the range of doses of cocaine tested, cocaine did not significantly affect response rates (Fig. 1d, bottom panels, open circles; F 4,12 = 0.41; NS). In contrast, DTG did not substitute for cocaine when administered i.v. at 5 min before testing (Fig. 1d, top panel, open squares) . The percent cocaine-appropriate responding was statistically different from that obtained with vehicle (F 4,12 = 3.31; P < 0.05). However, the subsequent post-hoc Bonferroni t-test indicated no significant differences in DTG dose (all t values r 2.90; all P values Z 0.053). The highest dose of DTG decreased response rates to less than 50% of control rates (Fig. 1d, lower panel, open squares) . . All test compounds were administered i.v. at 5 min before sessions. Note that the dopamine-uptake inhibitors dose-dependently produced cocaine-like responding and were fully substituted for cocaine, and that neither of the sR agonists produced cocaine-like responding that differed from vehicle. i.v., intravenously.
Similarly, PRE-084 did not substitute for cocaine when administered i.v. at 5 min before testing at doses from 0.032 to 5.6 mg/kg. The percent cocaine-appropriate responding was not significantly different from that obtained with vehicle (F 6,24 = 0.87; NS). The highest dose of PRE-084 decreased response rates to less than 50% of control rates (t = 3.41; P < 0.05).
Discussion
This study was initiated following studies showing that sR agonists were reinforcing in rats trained to self-administer cocaine (Hiranita et al., 2010) , suggesting that the drugs might possess cocaine-like subjective effects. In contrast to the self-administration results, neither of the sR agonists tested, PRE-084 or DTG, produced cocaine-like discriminative effects different from vehicle across the range of behaviorally active doses in rats trained to discriminate cocaine (10 mg/kg) from saline injections. As expected, based on previous reports (e.g. Colpaert et al., 1979; Witkin et al., 1991; Li et al., 2006) , the standard dopamine-uptake inhibitors, WIN 35 428 and methylphenidate, both fully substituted for cocaine.
Although the previous self-administration results suggested that sR agonists would produce cocaine-like discriminative effects, other studies have suggested otherwise. For example, in rats trained to discriminate injections of cocaine (10 mg/kg) from saline in a shock avoidance procedure (Ukai et al., 1997) , s.c. injections of DTG (1 and 10 mg/kg, 30 min before sessions) were no different from vehicle (see also Cohen and Sanger, 1995) . In addition, two recent studies on substitution of another sR agonist, SA 4503, in rats trained with food reinforcement to discriminate either cocaine (5.0 mg/kg; Rodvelt et al., 2011a) or methamphetamine (0.5 mg/kg; Rodvelt et al., 2011b) from saline also indicated a failure of that sR agonist to fully reproduce the discriminative-stimulus effects of those psychomotor stimulant drugs.
The absence of cocaine-like discriminative-stimulus effects of both PRE-084 and DTG was also obtained in this study with different pretreatment times (5 or 30 min before sessions). In addition, as the self-administration of sR agonists was obtained with i.v. injections, different routes of administration (i.p., s.c., or i.v.) were studied. The absence of cocaine-like discriminative-stimulus effects at different pretreatment times and different routes of administration further substantiated the distinctiveness of the discriminative-stimulus or subjective effects of sR agonists and those of psychomotor stimulants. Consistent with this suggestion are findings that rats trained to discriminate selective sR agonists (Steinfels et al., 1988; Holtzman, 1989 ) did not show substitution with cocaine or other psychostimulants. Other studies using drug discrimination procedures have demonstrated that the sR agonist, (+)-pentazocine, fully substituted in rats trained to discriminate drugs other than stimulants, ethanol (Hundt et al., 1998) or buprenorphine (Holtzman, 1997) . Together these previous results are consistent with the suggestion of little, if any, overlap of cocaine-like and sR-agonist discriminativestimulus effects. Thus, the reinforcing effectiveness of the sR agonists in rats with a history of cocaine selfadministration in a previous study (Hiranita et al., 2010) probably did not result from subjective effects of sR agonists that were similar to those of cocaine.
The standard dopamine-uptake inhibitors, WIN 35 428 and methylphenidate, both fully reproduced cocaine-like discriminative-stimulus effects, as has been shown previously (Colpaert et al., 1979; Witkin et al., 1991; Li et al., 2006) . Furthermore, the indirect agonists that release dopamine, such as d-amphetamine and methamphetamine, have been reported to produce full cocainelike discriminative-stimulus effects and dopamine receptor antagonists block the discriminative-stimulus effects of cocaine (Barrett and Appel, 1989; Witkin et al., 1991; Terry et al., 1994) . A previous study (Garcés-Ramírez et al., 2011) using in-vivo microdialysis showed that both PRE-084 and DTG increase concentrations of dopamine in the nucleus accumbens shell, a brain region important for the actions of abused drugs (Pontieri et al., 1995; Tanda et al., 1997) . However, the dose of PRE-084 that increased dopamine levels was approximately 30-fold higher than the dose that maintained responding in rats trained to self-administer cocaine (Hiranita et al., 2010) . Importantly, none of the selective sR antagonists BD 1008 or BD 1063 antagonized the neurochemical effects of PRE-084 (Garcés-Ramírez et al., 2011) indicating that those effects were not sR mediated. In contrast, the reinforcing effects of PRE-084 in self-administration studies were sensitive to the sR antagonists (Hiranita et al., 2010) . Thus, it seems that there is a separation in the pharmacological mechanisms underlying the reinforcing effects of cocaine and sR agonists, and it is likely that the separation of pharmacological mechanisms contributes to the differences in discriminative-stimulus effects.
In summary, this study demonstrated dissimilarities in the discriminative-stimulus effects of cocaine and selective sR agonists in rats. Those differences suggest that the reinforcing effects of the sR agonists (Hiranita et al., 2010) are not based on substantial overlap of the subjective effects of the two classes of drugs. Previous studies suggest a distinction between the neurochemical effects of cocaine and sR agonists that may contribute to the differences in subjective effects of the two classes of drugs.
animal housing facilities are fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International and all procedures were conducted in accordance with the guidelines of the Institutional Care and Use Committee of the NIDA Intramural Research Program and the 1996 National Research Council and Guide for Care and Use of Laboratory Animals.
